- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Accretion Pharmaceuticals IPO
₹1,15,200/1200 shares
Minimum Investment
IPO Details
14 May 25
16 May 25
₹1,15,200
1200
₹96 to ₹101
NSE
₹29.75 Cr
21 May 25
Accretion Pharmaceuticals IPO Timeline
Bidding Start
14 May 25
Bidding Ends
16 May 25
Allotment Finalisation
19 May 25
Refund Initiation
20 May 25
Demat Transfer
20 May 25
Listing
21 May 25
Accretion Pharmaceuticals Limited
Founded in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company engaged in manufacturing and marketing tablets, capsules, oral liquids, external preparations, and herbal products. It also offers contract manufacturing services. With ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, the company ensures quality and environmental compliance. Its manufacturing facility is based in Sanand, Ahmedabad, Gujarat. Accretion has a growing international presence in over 20 countries across Africa, Southeast Asia, and the Middle East. As of January 2025, the company employs 83 individuals, including four Executive Directors.
Accretion Pharmaceuticals Limited IPO Overview
Accretion Pharmaceuticals IPO is a book-built issue worth ₹29.75 crores, comprising a fresh issue of 29.46 lakh equity shares. The IPO opens for subscription on May 14, 2025, and closes on May 16, 2025. Allotment is expected to be finalised on May 19, with a tentative listing date of May 21, 2025, on the NSE SME platform. The price band is set between ₹96 and ₹101 per share. Retail investors can apply for a minimum of 1,200 shares, requiring an investment of ₹1,15,200; however, bidding at the cutoff price, approximately ₹1,21,200, is advised to avoid oversubscription issues. HNIs must apply for at least two lots (2,400 shares), totalling ₹2,42,400. Jawa Capital Services Private Limited is the book-running lead manager, Kfin Technologies Limited is the registrar, and Gretex Share Broking Private Limited serves as the market maker.
Accretion Pharmaceuticals Limited IPO Details
| Particulars | Details |
| IPO Date | 14 May 2025 to 16 May 2025 |
| Listing Date | 21 May 2025 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹96 to ₹101 per share |
| Lot Size | 1200 Shares |
| Total Issue Size | 29,46,000 shares (aggregating up to ₹29.75 Cr) |
| Fresh Issue | 29,46,000 shares (aggregating up to ₹29.75 Cr) |
| Offer for Sale | NA |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 81,70,000 shares |
| Share Holding Post Issue | 1,11,16,000 shares |
| Market Maker Portion | 1,47,600 shares |
Accretion Pharmaceuticals Limited IPO Reservation
| Investor Category | Shares Offered |
| QIB | Not more than 50% of the Net Issue |
| Retail | Not less than 35% of the Net Issue |
| NII (HNI) | Not less than 15% of the Net Issue |
Accretion Pharmaceuticals Limited IPO Lot Size
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 1,200 | ₹1,21,200 |
| Retail (Max) | 1 | 1,200 | ₹1,21,200 |
| HNI (Min) | 2 | 2,400 | ₹2,42,400 |
Accretion Pharmaceuticals Limited IPO Promoter Holding
| Shareholding Status | Percentage |
| Pre-Issue | 100.00% |
| Post-Issue | 73.48% |
Accretion Pharmaceuticals Limited IPO Valuation Overview
| KPI | Value |
| Earnings Per Share (EPS) | 4.74 |
| Price/Earnings (P/E) Ratio | TBD |
| Return on Net Worth (RoNW) | 72.47% |
| Net Asset Value (NAV) | 17.09 |
| Return on Equity | 72.47% |
| Return on Capital Employed (ROCE) | 36.73% |
| EBITDA Margin | |
| PAT Margin | 11.51% |
| Debt to Equity Ratio | 2.52 |
Objectives of the Proceeds
- Capital expenditure towards purchase of new equipment/machineries: ₹26.97 million
- Capital expenditure towards upgradation of existing manufacturing facility: ₹46.56 million
- Repayment/prepayment of certain borrowings availed by the Company: ₹9.92 million
- Funding working capital requirements: ₹146.80 million
- General corporate purpose
Key Financials (in ₹ crore)
SWOT Analysis of Accretion Pharmaceuticals IPO
Strength and Opportunities
- Experienced promoters with deep industry knowledge.
- Strong client and supplier relationships.
- Focused on high-quality pharmaceutical products.
- Certified for quality and environmental management systems.
- Expanding presence in emerging global markets.
- Rising demand for contract manufacturing services.
- Potential to introduce new healthcare products.
- Increasing global focus on affordable generics.
Risks and Threats
- Operations depend on a single manufacturing facility.
- Exposed to ongoing legal and regulatory proceedings.
- High compliance burden in international markets.
- Limited diversification in manufacturing locations.
Explore IPO Opportunities
Explore our comprehensive IPO pages to stay updated on the latest trends and insights.
About Accretion Pharmaceuticals Limited IPO
Accretion Pharmaceuticals IPO Strengths
- The company is led by experienced promoters and a capable management team.
- It has developed long-standing relationships with clients and suppliers.
- A strong focus is maintained on delivering quality products.
- The management has built a robust supply chain and customer relations, fostering goodwill and trust.
Peer Group Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (₹/share) | P/E (x) | RoNW (%) | P/BV Ratio |
| Accretion Pharmaceuticals Limited | 8.74 | 8.74 | 17.09 | 11.56 | 38.54 | 5.94 |
| Peer Groups | ||||||
| Sakar Healthcare Limited | 5.64 | 5.64 | 120.65 | 48.89 | 4.45 | — |
| Lincoln Pharmaceuticals Ltd. | 46.58 | 46.58 | 295.98 | 12.30 | 15.74 | 1.98 |
| Sotac Pharmaceuticals Limited | 5.24 | 5.24 | 43.69 | 23.85 | 11.91 | — |
How to apply IPO with HDFC SKY?
Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.
1Login to your HDFC SKY Account
2Select Issue
3Enter Number of Lots and your Price.
4Enter UPI ID
5Complete Transaction on Your UPI App
FAQs On Accretion Pharmaceuticals Limited IPO
How can I apply for Accretion Pharmaceuticals Limited IPO?
You can apply via HDFCSky, or other brokers using UPI-based ASBA (Application Supported by Blocked Amount).
When does the Accretion Pharmaceuticals IPO open and close?
The IPO opens on May 14, 2025, and closes on May 16, 2025, for public subscription.
What is the price band and lot size for the IPO?
The price band is ₹96–₹101 per share, and the minimum lot size is 1,200 shares.
Where will the shares be listed post-IPO?
The shares will be listed on the NSE SME platform on May 21, 2025.
What is the minimum investment amount for retail investors?
Retail investors must invest a minimum of ₹1,21,200, applying for one lot at the cutoff price.
By signing up I certify terms, conditions & privacy policy